NCT00479765 2022-06-22A Phase 1 / 2 Dose Escalation Study of Locally-Administered OncoGelâ„¢ in Subjects With Recurrent GliomaBoston Scientific CorporationPhase 1/2 Terminated4 enrolled 5 charts